Mistras Group (MG)
(Delayed Data from NYSE)
$8.38 USD
+0.04 (0.48%)
Updated May 17, 2024 04:00 PM ET
After-Market: $8.42 +0.04 (0.48%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Brokerage Reports
Mistras Group Inc [MG]
Reports for Purchase
Showing records 21 - 40 ( 210 total )
Company: Mistras Group Inc
Industry: Electronics - Miscellaneous Products
Company: Mistras Group Inc
Industry: Electronics - Miscellaneous Products
Company: Mistras Group Inc
Industry: Electronics - Miscellaneous Products
Company: Mistras Group Inc
Industry: Electronics - Miscellaneous Products
Company: Mistras Group Inc
Industry: Electronics - Miscellaneous Products
Company: Mistras Group Inc
Industry: Electronics - Miscellaneous Products
Company: Mistras Group Inc
Industry: Electronics - Miscellaneous Products
Company: Mistras Group Inc
Industry: Electronics - Miscellaneous Products
Company: Mistras Group Inc
Industry: Electronics - Miscellaneous Products
Company: Mistras Group Inc
Industry: Electronics - Miscellaneous Products
Company: Mistras Group Inc
Industry: Electronics - Miscellaneous Products
Company: Mistras Group Inc
Industry: Electronics - Miscellaneous Products
Company: Mistras Group Inc
Industry: Electronics - Miscellaneous Products
Engineering - Construction Change Order - E-C 1Q20 Preview
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Mistras Group Inc
Industry: Electronics - Miscellaneous Products
Company: Mistras Group Inc
Industry: Electronics - Miscellaneous Products
Engineering - Construction Change Order - E-C 1Q20 Preview
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Mistras Group Inc
Industry: Electronics - Miscellaneous Products
Company: Mistras Group Inc
Industry: Electronics - Miscellaneous Products
Initial Take on 4Q19 Results; No FY20 Guidance Provided
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Mistras Group Inc
Industry: Electronics - Miscellaneous Products
Engineering - Construction Change Order - E-C Playbook in the Wake of COVID-19
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department